Cutler Group’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,500
Closed -$30K 3746
2023
Q2
$30K Buy
+1,500
New +$30.4K ﹤0.01% 1594
2021
Q4
Sell
-517
Closed -$16.4K 5318
2021
Q3
$14K Sell
517
-2,000
-79% -$50.8K ﹤0.01% 3630
2021
Q2
$65K Sell
2,517
-760
-23% -$18.2K ﹤0.01% 2254
2021
Q1
$70K Buy
3,277
+990
+43% +$25K ﹤0.01% 2048
2020
Q4
$49K Buy
2,287
+1,787
+357% +$43.4K ﹤0.01% 2021
2020
Q3
$7K Sell
500
-800
-62% -$14.4K ﹤0.01% 3213
2020
Q2
$29K Sell
1,300
-33
-2% -$603 ﹤0.01% 2110
2020
Q1
$18K Sell
1,333
-4,967
-79% -$75.3K ﹤0.01% 2358
2019
Q4
$102K Buy
6,300
+6,000
+2,000% +$142K 0.01% 1191
2019
Q3
$10K Buy
+300
New +$14.3K ﹤0.01% 2612
2019
Q2
Sell
-9,000
Closed -$648K 4168
2019
Q1
$657K Sell
9,000
-2,900
-24% -$200K 0.07% 255
2018
Q4
$759K Buy
11,900
+11,500
+2,875% +$855K 0.07% 242
2018
Q3
$39K Sell
400
-3,110
-89% -$258K ﹤0.01% 1762
2018
Q2
$249K Buy
3,510
+410
+13% +$34.4K 0.02% 690
2018
Q1
$322K Sell
3,100
-3,011
-49% -$339K 0.03% 584
2017
Q4
$615K Buy
+6,111
New +$450K 0.03% 467

Other funds holding ANAB

Cutler Group's ANAB Position: Q3 2023 in Review

Cutler Group sold out of AnaptysBio (ANAB) in Q3 2023, closing a stake of 1,500 shares — an estimated $30K sold.

Cutler Group first reported a position in ANAB in Q4 2017 and held it in 16 quarters. The position peaked at $759K in Q4 2018. 116 funds tracked by Wall St. Rank hold ANAB as of Q3 2023.

  • Cutler Group reported no remaining AnaptysBio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 1,500 AnaptysBio shares in Q3 2023, an estimated $30K.
  • Cutler Group first reported a position in AnaptysBio in Q4 2017 and held it in 16 quarters.
  • Cutler Group's AnaptysBio position peaked at $759K in Q4 2018.
  • 116 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.